← Back to advisors

Maya Lin

◉Verified by Rebirthealth

Conventional medicineSenior advisor

Practicing in Tokyo, Japan · EN, JP, ZH

◯Taking new tasks

ABOUT

I am a medical oncologist with two decades of clinical work in Tokyo. My practice sits at the junction of Western-trained oncology and the integrative frameworks I absorbed from years of working alongside Japanese kampo pharmacologists. I do not promise miracle outcomes, but I bring an unusual ability to read between the lines of a case that other specialists have given up on. My approach is to treat the whole trajectory of illness, not just the current snapshot. When a client comes to me after three failed treatment lines, I look at what was tried, what was measured, what was overlooked, and what changed in the client's life circumstances that might be relevant. Most of my Rebirthealth cases involve late-stage cancers, treatment-resistant autoimmune conditions, and complex multisystem disorders. I believe that the most valuable thing I can offer through this platform is not a prescription but a structured second opinion — a fresh set of eyes that has seen thousands of cases across two medical systems.

CREDENTIALS

MD, Internal Medicine

University of Tokyo, 2009

✓ Verified

Board Certified, Oncology

Japanese Society of Medical Oncology, 2013

✓ Verified

Fellow, European Society for Medical Oncology

ESMO, 2018–present

✓ Verified

CASE EVIDENCE

Case · anonymized

A 54-year-old came to me after three years of unexplained chronic fatigue and joint pain. Multiple specialists had not found a unifying cause. Over four months of work, we identified an overlooked autoimmune overlap syndrome and a concurrent thyroid dysfunction. By the end of that period, the client reported energy levels returning to roughly 70% of their pre-illness baseline and joint flares reduced to once a month instead of daily. This case was verified by Rebirthealth against the original client's release.

Case · anonymized

A 41-year-old with stage IIIB non-small cell lung cancer, post two lines of failed chemotherapy. The referring oncologist had suggested palliative care only. I reviewed the full molecular profile and identified an uncommon but actionable mutation that had been tested but misinterpreted. A targeted therapy was initiated through the client's local team. Twelve months later, the disease was stable — not cured, but meaningfully stabilized. Verified by Rebirthealth.

Case · anonymized

A 67-year-old with treatment-resistant rheumatoid arthritis and concurrent liver concerns that made conventional biologics risky. I worked with the client's rheumatologist to design a low-hepatotoxicity protocol that combined a JAK inhibitor at reduced dose with specific kampo formulations. After six months, inflammatory markers had decreased by 60% and the client was able to resume gardening — their stated quality-of-life goal. Verified by Rebirthealth.

Case · anonymized

A 38-year-old experiencing unexplained progressive peripheral neuropathy. After reviewing five years of medical records across three countries, I identified a pattern consistent with a rare paraneoplastic syndrome. A targeted scan confirmed a small, previously undetected tumor. Early intervention was possible because the pattern was caught. This case was one of the most satisfying detective-work outcomes in my career. Verified by Rebirthealth.

PLATFORM HISTORY

Tasks completed23 tasksAvg response time~8 hours to first proposalAvg peer score8.2 / 10Working languagesEN, JP, ZHJoinedMarch 2024

CLIENT FEEDBACK

24 of 26 clients marked this advisor's work as "what they hoped for"

“The first time I felt like a professional really sat with my case before answering. The written plan was something I could actually follow.”

— Client, Chronic illness, Q2 2025

“I had been told by three specialists that my situation was unusual. Her approach was the first one that took the unusual part seriously instead of trying to normalize it.”

— Client, Rare condition, Q4 2024